William Blair Investment Management LLC Sells 98,432 Shares of LeMaitre Vascular, Inc. (LMAT)

William Blair Investment Management LLC reduced its position in LeMaitre Vascular, Inc. (NASDAQ:LMAT) by 37.3% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 165,494 shares of the medical instruments supplier’s stock after selling 98,432 shares during the period. William Blair Investment Management LLC owned 0.88% of LeMaitre Vascular worth $5,167,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also bought and sold shares of the company. Columbia Wanger Asset Management LLC increased its position in LeMaitre Vascular by 21.0% in the first quarter. Columbia Wanger Asset Management LLC now owns 1,093,903 shares of the medical instruments supplier’s stock worth $26,943,000 after buying an additional 189,608 shares during the last quarter. Conestoga Capital Advisors LLC increased its position in LeMaitre Vascular by 45.8% in the second quarter. Conestoga Capital Advisors LLC now owns 565,069 shares of the medical instruments supplier’s stock worth $17,641,000 after buying an additional 177,379 shares during the last quarter. Bank of New York Mellon Corp increased its position in LeMaitre Vascular by 137.9% in the second quarter. Bank of New York Mellon Corp now owns 210,628 shares of the medical instruments supplier’s stock worth $6,574,000 after buying an additional 122,076 shares during the last quarter. Russell Investments Group Ltd. increased its position in LeMaitre Vascular by 211.2% in the first quarter. Russell Investments Group Ltd. now owns 150,413 shares of the medical instruments supplier’s stock worth $3,705,000 after buying an additional 102,078 shares during the last quarter. Finally, Ameriprise Financial Inc. increased its position in LeMaitre Vascular by 52.3% in the first quarter. Ameriprise Financial Inc. now owns 201,508 shares of the medical instruments supplier’s stock worth $4,963,000 after buying an additional 69,186 shares during the last quarter. Institutional investors own 67.12% of the company’s stock.

Shares of LeMaitre Vascular, Inc. (NASDAQ LMAT) opened at 34.07 on Friday. LeMaitre Vascular, Inc. has a 12 month low of $17.50 and a 12 month high of $36.09. The company has a 50-day moving average of $31.97 and a 200 day moving average of $28.18. The company has a market capitalization of $648.08 million, a P/E ratio of 48.67 and a beta of 0.65.

LeMaitre Vascular (NASDAQ:LMAT) last released its quarterly earnings data on Thursday, July 27th. The medical instruments supplier reported $0.23 earnings per share for the quarter, beating the consensus estimate of $0.17 by $0.06. The business had revenue of $25.80 million for the quarter, compared to analyst estimates of $25.42 million. LeMaitre Vascular had a return on equity of 15.02% and a net margin of 14.19%. LeMaitre Vascular’s revenue was up 15.2% compared to the same quarter last year. During the same period last year, the firm posted $0.14 earnings per share. Analysts forecast that LeMaitre Vascular, Inc. will post $0.80 EPS for the current year.

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, September 7th. Investors of record on Wednesday, August 23rd will be paid a $0.055 dividend. This represents a $0.22 annualized dividend and a yield of 0.65%. The ex-dividend date is Monday, August 21st. LeMaitre Vascular’s dividend payout ratio (DPR) is presently 31.88%.

LeMaitre Vascular announced that its board has authorized a stock repurchase plan on Thursday, July 27th that allows the company to repurchase $7.50 million in outstanding shares. This repurchase authorization allows the medical instruments supplier to purchase up to 1.4% of its shares through open market purchases. Shares repurchase plans are typically a sign that the company’s leadership believes its stock is undervalued.

WARNING: “William Blair Investment Management LLC Sells 98,432 Shares of LeMaitre Vascular, Inc. (LMAT)” was first reported by Transcript Daily and is owned by of Transcript Daily. If you are accessing this report on another site, it was illegally stolen and reposted in violation of United States and international copyright and trademark legislation. The legal version of this report can be viewed at https://transcriptdaily.com/2017/08/27/william-blair-investment-management-llc-sells-98432-shares-of-lemaitre-vascular-inc-lmat.html.

LMAT has been the topic of a number of recent research reports. Canaccord Genuity downgraded shares of LeMaitre Vascular from a “buy” rating to a “hold” rating and set a $28.00 price target on the stock. in a research report on Monday, July 10th. Benchmark Co. downgraded shares of LeMaitre Vascular from a “buy” rating to a “hold” rating in a research report on Monday, July 10th. They noted that the move was a valuation call. Craig Hallum initiated coverage on shares of LeMaitre Vascular in a research report on Tuesday, June 6th. They issued a “hold” rating and a $31.00 price target on the stock. BidaskClub downgraded shares of LeMaitre Vascular from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, July 25th. Finally, Zacks Investment Research downgraded shares of LeMaitre Vascular from a “buy” rating to a “hold” rating in a research report on Tuesday, July 4th. Five research analysts have rated the stock with a hold rating and four have given a buy rating to the stock. LeMaitre Vascular has a consensus rating of “Hold” and a consensus price target of $30.17.

In related news, Chairman George W. Lemaitre sold 58,700 shares of the firm’s stock in a transaction dated Thursday, August 3rd. The stock was sold at an average price of $33.97, for a total value of $1,994,039.00. Following the sale, the chairman now directly owns 3,471,808 shares of the company’s stock, valued at $117,937,317.76. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, CEO George W. Lemaitre sold 10,000 shares of the firm’s stock in a transaction dated Monday, August 7th. The shares were sold at an average price of $33.62, for a total value of $336,200.00. Following the completion of the sale, the chief executive officer now directly owns 3,436,808 shares in the company, valued at $115,545,484.96. The disclosure for this sale can be found here. Insiders sold 288,784 shares of company stock worth $9,720,587 over the last ninety days. 23.70% of the stock is currently owned by insiders.

About LeMaitre Vascular

LeMaitre Vascular, Inc is a provider of medical devices for the treatment of peripheral vascular disease. The Company develops, manufactures and markets medical devices and implants used primarily in the field of vascular surgery. It is engaged in the design, marketing, sales and technical support of medical devices and implants for the treatment of peripheral vascular disease industry segment.

Want to see what other hedge funds are holding LMAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for LeMaitre Vascular, Inc. (NASDAQ:LMAT).

Institutional Ownership by Quarter for LeMaitre Vascular (NASDAQ:LMAT)

Receive News & Ratings for LeMaitre Vascular Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LeMaitre Vascular Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply